Ongoing trials in our laboratory indicate that ddCTC are more frequently detected than CTC characterized by AdnaTestBreastCancerSelect and Detect kits (GA733-2, Muc-1 and Her-2) in primary breast cancer patients. This evidence concerns the gene ERBB2 and breast carcinoma.